Trial intelligence / Profile preview

Riluzole in advanced melanoma

NCT00866840Phase 2Completed

Sponsor
Rutgers University
Start
Apr 2009
Primary completion
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of riluzole in melanoma, sponsored by Rutgers University. Started Apr 2009; status: completed.

02

Drugs

riluzole
03

Conditions

melanoma

Beyond the preview

Go deeper on NCT00866840.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00866840.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call